A total of 10 SULT genes are presently known to be expressed in human tissues. We performed a comprehensive genome-wide search for novel SULT genes using two different but complementary approaches, and developed a novel graphical display to aid in the annotation of the hits. Seven novel human SULT genes were identified, five of which were predicted to be pseudogenes, including two processed pseudogenes and three pseudogenes that contained introns. Those five pseudogenes represent the first unambiguous SULT pseudogenes described in any species. Expression-profiling studies were conducted for one novel gene, SULT6B1, and a series of alternatively spliced transcripts were identified in the human testis. SULT6B1 was also present in chimpanzee and gorilla, differing at only seven encoded amino-acid residues among the three species. The results of these database mining studies will aid in studies of the regulation of these SULT genes, provide insights into the evolution of this gene family in humans, and serve as a starting point for comparative genomic studies of SULT genes.
INTRODUCTION
Sulfate conjugation is an important pathway in the biotransformation of many exogenous and endogenous compounds including drugs, other xenobiotics, neurotransmitters, and hormones. 1, 2 The cytosolic SULT enzymes that catalyze these reactions are members of a gene superfamily. Cytosolic SULTs are usually active as homodimers and share two highly conserved regions of the amino-acid sequence, termed Regions I and IV. 1, 3 These regions of sequence are important in binding the cosubstrate sulfate donor molecule 3 0 -phosphoadenosine 5 0 -phosphosulfate (PAPS). [4] [5] [6] In addition, Region IV forms part of the dimerization interface region for these enzymes. 7 SULTs can be classified into families whose members share at least 45% amino-acid sequence identity, and subfamilies that include enzymes that share at least 60% amino-acid sequence identity. 3, 8 It should be noted that the membrane-bound sulfotransferases which are located in the golgi and catalyze the sulfation of macromolecules form a superfamily distinct from that of the cytosolic SULTs, 9 and were not included in the present study.
In all, 10 cytosolic SULT genes are presently known to be expressed in human tissues: SULTs 1A1, 1A2, 1A3, 1B1, 1C1, 1C2, 1E1, 2A1, 2B1, and 4A1. 3, [10] [11] [12] [13] [14] [15] While the cDNAs for some of those genes were cloned after purification and sequencing of the expressed protein, many were subsequently identified and cloned using homology-based techniques that took advantage of the highly conserved sequences in Regions I and IV. Eight of the human genes were characterized using PCR and DNA sequencing methods, 12, [16] [17] [18] [19] [20] [21] but the genes for SULT1B1 and 4A1 were characterized by annotation of publicly available genomic sequence data generated by the Human Genome Project (unpublished observations 22 ). All 10 of these genes share very similar gene structures, both with regard to the number and length of coding exons as well as the locations of splice junctions within the translated amino-acid sequence ( Figure 1 ).
In the present study, we took advantage of the genomic sequence data available in public databases, and set out to perform a comprehensive genome-wide search for novel human SULT genes and complete annotation of the known SULT gene clusters. We used two different but complementary approaches to search the public sequence database. The first approach utilized explicit SULT query sequences and BLAST 23 searches, followed by the use of two different, more sensitive sequence alignment programs. The second approach used the HMMER 24 and GeneWise 25 programs, both of which used a hidden Markov model (HMM) profile 26 as a query. In addition, we developed a novel graphical display to view the results of the searches, thereby improving the efficiency of the manual annotation step.
A total of seven novel SULT genes were identified in addition to the 10 already known to be expressed in humans. Five of the seven were predicted to be pseudogenes based either on sequence mutations or exon rearrangement.
Three of those five contained introns and two were processed pseudogenes-the first SULT processed pseudogenes to be described in any species. The remaining two genes, SULT1C3 and SULT6B1, contained no obvious inactivating mutations. Expression-profiling studies failed to detect any SULT1C3 transcripts; so this gene is probably more accurately described as a 'putative' gene. A series of alternatively spliced SULT6B1 transcripts were identified in the testis, confirming the expression of this gene in humans. SULT6B1 is also highly conserved in two primate species closely related to humans, the chimpanzee and gorilla. The results of this database mining exercise will aid in future studies of the regulation of these genes, will provide insights into the evolution of this gene family in humans, and will serve as a starting point for future comparative genomic studies of SULT genes.
RESULTS

BLAST and Sequence Alignment Searches
To perform the first search of the human genome sequence database, 17 SULT protein sequences were selected for use as query sequences in a TBLASTN search. Those query sequences included the 11 SULT isoforms encoded by the 10 genes known to be expressed in humans (SULT2B1 encodes two isoforms as a result of alternative splicing), four non-human SULT sequences that represented families or subfamilies that contained no known human orthologs or paralogs, and two different consensus sequences. These 17 TBLASTN searches produced a total of 1765 hits that were each annotated manually. In total, 996 hits (56%) corresponded to one of the 10 SULT genes known to be expressed in humans, 422 (24%) were hits to novel (previously uncharacterized) SULT genes, 71 (4%) were determined to be nonspecific, and 276 (16%) were ambiguous and retained for further analysis. The 276 ambiguous hits were reduced to 195 nonredundant hits that represented different regions of genomic sequence, as well as one hit from each of the 10 known human SULT genes. A 500 kb region surrounding each of those 195 hits was then searched using the FrameSearch and TFastA programs. Approximately 10 360 searches were performed with those two programs, generating 39 125 hits (29 395 from TFastA and 9730 from FrameSearch). To aid in the annotation of those hits, a filter was developed that removed 32 798 hits (84%), leaving 6327 for further analysis. This filter is described in detail in the Materials and methods section. After plotting and analyzing those hits, seven novel SULT genes were identified and annotated.
After the novel SULT genes were annotated, we performed a second round of searches, using four of the seven novel SULT sequences as queries for TBLASTN. In all, 303 hits were returned and annotated. Of those, 256 (84%) corresponded to known SULT genes and eight hits were retained for further analysis. The follow-up analysis included 440 queries performed between the FrameSearch and TFastA programs, producing 1737 hits. Altogether, 1492 (86%) of those hits 98  181  95  127   98  95  181  95  127   >113  >164  98  181  95  127   499   196   337   98  181  95  127   98  181  95  127   98  181  95  127   209  544  152   215  209   126   126   126   126   126   126   129   172   152   152   152   347   113  113  88   74   154   542   432 Exon length (bp) Figure 1 Previously-characterized human SULT gene structures. Structures for the 10 SULT genes that are known to be expressed in humans and that have been reported previously are illustrated. Black boxes represent coding region, white boxes represent UTR, and hatched boxes represent alternatively spliced regions. Lengths are listed for each exon (in bp) and for the overall gene (in kb).
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were eliminated by the filter. No additional SULT genes were identified after annotating the remaining 245 hits.
HMMER and GeneWise Searches
In parallel with the first approach, a separate but complementary strategy that utilized HMMs was also used to search for novel SULT genes. Initially, a HMM profile was constructed using the sequences of the 11 human SULT isoforms known to be expressed in humans. That profile was calibrated and used with the HMMER program to search a six-fold translation of the human genome sequence, producing 181 hits. Annotation revealed that 111 hits (61%) corresponded to one of the 10 known or seven novel SULT genes identified using the initial strategy, 54 hits (30%) were nonspecific, and 16 (9%) were not readily classifiable and were included in the next step.
To verify the HMMER results and refine those sequence alignments, the GeneWise program was used to search all genomic contigs identified by the HMMER search that contained either one of the 17 SULT genes or one of the 16 unclassified hits. GeneWise produced a total of 384 hits. A total of 119 (31%) hits corresponded to SULT genes and 265 (69%) were nonspecific. All seven of the novel SULT genes that had been found during the BLAST-based approach were also identified using the HMM strategy, but no additional novel genes were observed.
Annotation of SULT Genes and Genomic Organization of SULT Gene Clusters
Following identification of the seven novel human SULT genes, each of those genes was annotated at the sequence level using a manual homology-based approach. Local sequence alignments, as well as the knowledge of conserved SULT gene structures (Figure 1 ), were employed during that annotation process. Of the total of 17 SULT genes that are now known, 13 are found in gene clusters on chromosomes 2q, 4q, 16p, and 19q (Table 1) . Each of the gene structures will be described subsequently, organized on the basis of chromosomal location. Annotations for the seven novel genes were deposited in the GenBank Third Party Annotation database under TPA accession numbers BK001431-BK001437.
The Chromosome 2 Cluster and SULT6B1
The four human members of the SULT1C subfamily are located in a cluster at 2q12, and the SULT6B1 gene maps to 2p22.3. The gene structures for SULT1C1 (approximately 20 kb long) and SULT1C2 (about 10 kb in length) have been reported previously. 21 Both the SULT1C1 and SULT1C2 genes contain seven exons that encode the protein ( Figure  1 ). However, the SULT1C1 gene contains an additional 5 0 -noncoding exon as well as a rarely expressed alternatively spliced exon located within intron 3. The structures for both of those genes were confirmed during the present study. In addition to those two genes, this study also identified two other genes located within the SULT1C gene cluster: SULT1C3 and SULT1C1P.
The nine putative protein-coding exons of SULT1C3 span approximately 18 kb (Figure 2a ). While SULT1C3 shares many features with other SULT1 family genes (Figure 1 ), the structure of this gene also contains unusual characteristics. First, the initial coding exon for SULT1C3 contains three inframe ATG codons that would result in proteins 304, 294, or 284 amino acids in length-lengths similar to those of other known SULT isoforms. The sites that would produce the shortest two proteins conformed slightly better to the canonical translation initiation sequence 27 than did the third site. Second, exons 7 and 8 are duplicated in SULT1C3 ( Figure 2a) ; so alternative splicing might occur for exons 7a, 7b, 8a, and 8b. The peptide sequences encoded by exons 7a and 7b are 61.7% identical to each other, and the peptide sequences encoded by exons 8a and 8b are 78.4% identical. Each exon is flanked by GT-AG dinucleotides and maintains the ORF, so alternative splicing could potentially produce four SULT1C3 proteins. Each of these four potential allozymes was named according to the exons 7 and 8 that it contained: SULT1C3a (exons 7a and 8a), SULT1C3b (7a/8b), SULT1C3c (7b/8a), and SULT1C3d (7b/8b). A transcript containing exons 7b and 8a would require a nonstandard splicing process due to the genomic arrangement of those exons and, as a result, would seem quite unlikely. The three putative proteins encoded by SULT1C3a-d are 60-68% identical to the rat SULT1C1 sequence and 53-58% identical to human SULT1C1 and SULT1C2.
SULT1C1P contains at least seven exons and spans approximately 18 kb (Figure 2b ). However, this gene has undergone rearrangement, since exons 2-5 are located 3 0 to exons 6-8. In addition, this gene lacks an in-frame ATG start The chromosomal localizations for each of the 17 human SULT genes are listed. Obvious pseudogenes are indicated by a 'P' after their name. In most cases, experimental evidence supports the map locations listed in the table (see text for details). However, the locations of several of the novel genes are based only on map locations for the genomic contigs from which they were annotated.
codon near the expected location in the predicted exon 2 sequence, and the splice junctions at the 3 0 ends of exons 3, 6, and 7 are not GT. There is also a premature stop codon within exon 8, possibly resulting from a 1 bp deletion in a tyrosine codon conserved in most SULT genes. For these reasons, this gene was designated a pseudogene (indicated by the trailing P in the name) and, since its hypothetical translated sequence was most similar to SULT1C1, it was given SULT1C1 as its base name. The order of the four genes in the SULT1C cluster is cen-SULT1C3-SULT1C1-SULT1C1P-SULT1C2-ter. The genes are located approximately 23, 5, and 45 kb apart, respectively.
SULT6B1 is located near 2p22.3, on the opposite arm of chromosome 2 relative to the SULT1C gene cluster. SULT6B1 contains seven putative protein-coding exons that span approximately 21 kb, and has a structure very similar to those of other SULT genes (Figure 2a) . Homology-based prediction of the location of the ATG start codon in exon 2 indicated that this exon is at least 199 bp in length. However, RACE and the expression-profiling experiments described subsequently indicated that the probable start codon was located much farther downstream than predicted, and revealed that exon 2 was only 106 bp in length. Those experiments also identified four noncoding exons upstream of exon 2, bringing the total length of SULT6B1 to approximately 29 kb. In addition, experiments designed to detect alternatively spliced transcripts identified a second exon 4-like sequence (termed exon 4b) located between exons 4 and 5. The predicted protein sequence of SULT6B1 was most similar to that of chicken SULT6A1 (52% identity, 63% similarity) and, based on the nomenclature that has been suggested for SULT genes, 8 this novel SULT was classified as the first member of the SULT6B subfamily. Portions of this gene were subsequently annotated by NCBI 0 s automated gene prediction software as 'similar to sulfotransferase family'.
The Chromosome 4 Cluster
Three SULT genes are located at chromosome 4q13: SULT1E1 and SULT1B1, both of which encode previously characterized proteins, and SULT1D1P, a gene identified during the present database searches. The gene structure for SULT1E1 was reported previously.
17 SULT1E1 contains seven exons that encode the protein, as well as an additional upstream noncoding exon, and is approximately 18 kb in length ( Figure 1 ). SULT1B1 also contains seven protein-coding exons that span 28 kb (Figure 1 ), but since no RACE data were reported for this gene, no noncoding regions could be identified.
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SULT1D1P shares homology with the conserved gene structures for other SULT1 family genes (Figure 2b) , and is about 22 kb in length. A potential TATA box (TATTAA) is located 60 bp upstream of the putative translation initiation codon. Only one other human SULT gene, SULT1E1, contains a TATA box. 17 A stop codon is present in exon 8 near the expected location, and seven polyadenylation signals are present within the subsequent 1800 bp. While those features suggested that this gene might be active, exon 2 contains two in-frame stop codons after the predicted ATG start codon, and the GT dinucleotides that comprise the anticipated splice sites at the ends of exons 2 and 4 have been mutated to GA and AT, respectively. Examples of GA-AG splicing have been reported. 28, 29 However, while it is known that introns may (rarely) splice using AT-AC pairs, 29, 30 to our knowledge, there are no examples of introns in humans that utilize AT-AG sequences. 29 Therefore, SULT1D1P was classified as a pseudogene and assigned the name 1D1 because of the high homology of the hypothetical protein product to mouse SULT1D1 (80% identical, 85% similar). The SULT1D1P gene is found approximately 36 kb telomeric to SULT1B1, and the SULT1E1 gene is located about 28 kb telomeric to SULT1D1P.
The Chromosome 16 Cluster
Three SULT genes are located on chromosome 16p11.2-12.1: SULT1A1, SULT1A2, and SULT1A3. The structures of all three of these genes have been reported previously, 16, 19, 20 and those structures were confirmed during the present studies. All three genes contain multiple 5 0 -noncoding exons and seven exons that encode protein, with exon lengths that match the conserved gene structures found among other SULT1 family genes ( Figure 1 ). The SULT1A genes are approximately 4.4, 5.1, and 7.3 kb in length, respectively. Therefore, they are much shorter than most other SULT genes. The assembly of this region of chromosome 16 is still incomplete, so no conclusions can presently be drawn with regard to the orientation of these genes relative to each other.
The Chromosome 19 Cluster
Two members of the human SULT2 family are located at chromosome 19q13.33. SULT2A1 is about 16 kb long, while SULT2B1 is approximately 48 kb in length (Figure 1) . Both of these genes have six exons that encode the protein, but the SULT2B1 gene has an alternative initial coding exon that is alternatively transcribed and is spliced to a site within the ORF (Figure 1 ). Both of these gene structures were reported previously, 12, 18 and both were confirmed in the course of this study.
The third member of the human SULT2 family is the novel SULT2A1P pseudogene, located at 19q13.4. This gene contains an in-frame ATG codon at the expected start site in exon 2, but it lacks an identifiable exon 7 sequence (Figure 2b ). Exon 6 contains a frame shift and is truncated by a MER85 repetitive sequence element, deleting the 5 0 -terminus of the highly conserved region IV sequence found at this location in other SULT genes. Two copies of exon 4 were found that are 68% identical (76% similar) to each other on the basis of predicted amino-acid sequence. The splice site located at the 5 0 -end of exon 4a is CG rather than AG, and exon 4b contains a stop codon. Finally, the most recent assembly of this region indicates that exons 2 and 3 are located on the opposite strand and approximately 131 kb away from exons 4b, 4a, 5, and 6. Therefore, this gene was classified as a pseudogene and named 2A1P, since the hypothetical translation of the truncated gene is 56% identical (66% similar) to human SULT2A1. SULT2A1P is about 153 kb long and is located approximately 7.76 Mb telomeric to SULT2B1, which is in turn located about 665 kb telomeric to SULT2A1, making the SULT2 'cluster' by far the longest of the SULT gene clusters. Unlike the other SULT gene clusters, the orientation of the genes in the SULT2 cluster is variable. The SULT2A1 gene and exons 4-6 of SULT2A1P are on the same strand, opposite that of exons 2-3 of SULT2A1P and SULT2B1.
SULT4A1
SULT4A1 is located on chromosome 22q13.31. The gene spans 38 kb, making it one of the longest human SULT genes ( Figure 1 ). Like SULT1B1, the structure of SULT4A1 had not been reported previously, but it was readily annotated during our studies. While SULT4A1 contains seven coding exons and shares some homology with the conserved SULT gene structures, the lengths of several of the exons differ significantly from those found in other SULT genes. 5 0 -and 3 0 -RACE studies have not been reported for this gene, so the number of noncoding exons is not known for SULT4A1.
SULT1D2P and SULT3A1P
SULT1D2P and SULT3A1P are located on chromosomes 3 and 14, respectively (Figure 2b ). Both are processed pseudogenes and represent the first reported SULT processed pseudogenes in any species. SULT1D2P contains five stop codons and three frame shifts, as well as a 349 bp Alu element inserted approximately 297 bp into the sequence. The predicted encoded amino-acid sequence of SULT1D2P shares 69% identity (75% similarity) with the predicted translation of the human SULT1D1P gene. Human SUL-T3A1P contains four stop codons and a single frame shift.
The predicted translation of the SULT3A1P pseudogene is 51% identical and 63% similar to that of mouse SULT3A1.
Expression Profiling of SULT1C3 and SULT6B1 Of the seven novel SULT genes which we identified, only SULT1C3 and SULT6B1 do not contain any obvious inactivating mutations (Figure 2a ). Therefore, both computational and experimental approaches were used to perform preliminary expression profiling studies for these two genes. Initially, the predicted peptide sequences encoded by both genes were used as queries in a TBLASTN search of the EST database. No ESTs were identified, indicating that, at present, there is no in silico evidence for the expression of either SULT1C3 or SULT6B1. Therefore, we also searched for evidence of expression by using PCR and cDNAs from 20 different human tissues. No SULT1C3 products were detected, even after performing nested amplifications. Therefore, on the basis of our data, the SULT1C3 gene is more accurately described as a putative active gene. However, SULT6B1 products were detected when testicular cDNA was used as template. Therefore, cDNA from this tissue was used to perform 5 0 -and 3 0 -RACE analysis.
SULT6B1 RACE
Marathon-Readyt human testis cDNA was used to perform RACE for SULT6B1. Analysis of 15 3 0 -RACE clones indicated that there were three functional polyadenylation signals, resulting in 3 0 -UTR lengths of 52, 80, and 113 bp. Initial attempts at 5 0 -RACE failed, so a new set of primers was designed that hybridized farther 3 0 -downstream from the predicted ATG translation initiation site. Products were generated successfully with the new primers, and 12 5 0 -RACE products were cloned and sequenced. Four exons were found upstream of the first predicted coding exon (Figure 3) , one of which (exon 1B) utilized two different 3 0 splice sites, creating a 'short' and 'extended' form of that exon. Three different transcription initiation sites were identified (upstream of exons 1D, 1C, and 1A). Finally, six different splicing patterns were observed, all of which spliced into the same location within the predicted exon 2 sequence ( Figure  3 ). That splice site was located 3 0 of both the computationally predicted translation initiation site and the first set of 5 0 -RACE primers, indicating that the in silico prediction of exon 2 extended too far upstream and that an alternate translation initiation site was used. Examples of each of the six splicing patterns have been submitted to GenBank (accession numbers AY289770-AY289775).
SULT6B1 Transcript Characterization
To characterize full-length SULT6B1 transcripts, primers located in the 5 0 -and 3 0 -UTRs were used to perform PCR with human testicular cDNA as template. Analysis of the products indicated that alternative splicing and exon skipping was common. In all, 11 different transcripts were characterized from 19 clones. 'Complete' transcripts consisting of coding exons 2-8 were found downstream of exons 1A (two clones), 1C-1B (two clones), 1D (three clones), and 1D-1B (one clone). Exon 5 was skipped (1D-1B-2-3-4-6-7-8) in a single transcript, as was exon 6 (1A-2-3-4-5-7-8). In addition, two transcripts were isolated that lacked exons 4, 5, and 6. Three clones contained exons 1D-2-3-7-8 and two clones contained exons 1D-1B-2-3-7-8. Finally, an additional exon (termed exon 4b) was identified. Exon 4b was flanked by GT-AG dinucleotides and was 84 bp in length. It maintained the open reading frame, but it also contained a stop codon. Exon 4b was identified in three different splice forms, two of which simultaneously lacked exon 6: 1A-2-3-4-4b-5-6-7-8 (two clones), 1A-2-3-4-4b-5-7-8 (one clone), and 1C-1B-2-3-4-4b-5-7-8 (one clone). Among all of these transcripts, only those that contained exons 2-8 or exons 2-3-7-8 remained in frame. Even though the transcripts that skip exons 4-6 include the conserved Region I and IV sequences common to SULT enzymes, it seems unlikely that the resulting peptide will have SULT activity.
Cloning SULT6B1 from Other Primate Species Each exon of the SULT6B1 gene was amplified from chimpanzee and gorilla genomic DNA using the PCR. The predicted amino-acid translations were compared to the predicted human sequence (Table 2) . A total of 13 ORR nucleotide differences were found among the three species. Nine amino acids were altered, while four were unchanged. The predicted sequences of the human, chimpanzee, and gorilla enzymes were 97% identical to each other. The exon sequences from chimpanzee and gorilla have been deposited in GenBank (accession numbers AY289776-AY289789).
DISCUSSION
Sulfation is an important pathway in the biotransformation of many drugs as well as endogenous compounds such as hormones and neurotransmitters.
1,2 Therefore, it is important to explore the possibility of pharmacogenetic variation in this pathway for drug metabolism. That process began 
The locations and sequences of the differences found in the predicted ORF sequences of human, gorilla, and chimpanzee SULT6B1 are listed. Nucleotide and amino-acid locations correspond to the human sequence.
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nearly two decades ago when biochemical genetic studies of SULT1A1 and SULT1A3 demonstrated that levels of activity for both of these SULT isoforms in the human platelet had high heritability. [31] [32] [33] More recently, a series of gene resequencing and functional genomic studies have resulted in the identification of functionally significant genetic polymorphisms for SULT1A1, 34 SULT1A3, 35 SULT1E1, 36 and SULT2A1. 37 One of the SULT1A1 polymorphisms has already been reported to be of pharmacogenetic significance for variation in the survival of breast cancer patients treated with tamoxifen. 38 Therefore, it is important for pharmacogenetics that all human genes encoding cytosolic SULTs be identified and characterized. The present studies represent the first comprehensive database mining project conducted to identify and annotate SULT genes in humans. We identified seven novel SULT genes in addition to the 10 that were previously reported to be expressed in humans. We also found evidence for the expression of SULT6B1, one of the two novel genes that appeared most likely to be expressed in human tissues.
The strategy used to search the human genome database involved two different but complementary approaches: one that used explicit SULT sequences as queries, and the other that utilized HMM profiles. The first approach began by using the TBLASTN program to perform an initial screen of the genome. Genomic contigs containing hits of interest were then scanned using two additional programs that employ different alignment algorithms. The TFastA program was chosen for speed and, in some cases, for its increased sensitivity over TBLASTN. The FrameSearch program was used for its ability to perform a Smith and Waterman local alignment using a protein sequence as a query and all possible codons in a nucleotide database. To aid in the annotation of the large number of hits generated by use of those two programs, a graphical display was created that conveyed on a single graph multiple levels of information with regard to each hit. As shown in Figure 4 , both programs identified most of the exons in all SULT genes. However, many hits were identified by only one of the two programs. For example, TFastA found most of the exons in the SULT1C1P gene, but FrameSearch found none. Therefore, our decision to use multiple alignment programs based on different algorithms and then combine the datasets prior to analysis greatly aided in the identification and annotation of novel SULT genes.
The second approach that was used to search the human genome used HMM profiles rather than explicit amino-acid sequences. HMMs contain position-specific scoring that contains information about the degree of conservation of each residue, making HMM searches more sensitive than pair-wise alignment methods like those used in the initial approach. A HMM profile was created using the sequences of the 11 human SULT enzymes known to be expressed (SULT2B1 produces two isoforms), and that profile was used with the HMMER program to search a six-fold translation of the human genome database. Genomic contigs containing hits of interest were identified and subsequently searched using the GeneWise program. GeneWise also uses HMM profiles, but it is able to search a nucleotide database directly. In addition, GeneWise can compensate for gaps in the alignment due to either sequencing error or introns.
Those searches resulted in the identification of several novel SULT genes, including SULT6B1, the first human SULT gene in family 6 and only the second member of that family to be identified in any species. A series of alternatively spliced SULT6B1 transcripts was identified in the testis, confirming the expression of this gene and forming the basis for future functional studies. In addition to SULT6B1, a previous report 39 suggested that a third member of the SULT1C family existed in humans on the basis of partial exon sequence of a putative human homolog of rat SULT1C1, although the full sequence and structure of that gene remained unknown. The present studies have successfully identified and annotated the structure of that gene, SULT1C3. While SULT1C3 has the potential to be active on the basis of nucleotide sequence, no experimental evidence was found which supported the transcription of that gene in the tissues in the cDNA panel or in the MTE array. However, it is possible that SULT1C3 is expressed at a different time during development or under different physiological conditions than when the tissue samples for the cDNAs panel and the MTE array were prepared. Therefore, the question of whether this gene is expressed in humans remains open until SULT1C3 transcripts are detected. After we had identified and studied these two genes, both of them were deposited in GenBank as a result of patent filing WO 0164904 for SULT6B1 and patent filing WO 9172977 for SULT1C3. and the exon that was used as a query sequence to generate the hit (y-axis). Points above the x-axis are hits on the forward strand, while points below the x-axis represent hits on the reverse strand.
The relative size of each data point indicates either the percent identity of the hit to the query exon sequence (top graph) or the length of the overall alignment (bottom graph). On these plots, hits corresponding to SULT genes form clear diagonals (circled in green) that are readily distinguishable from the nonspecific hits that are scattered throughout the plot. One exception is the SULT1C1P gene, which does not form a diagonal. That is a result of rearrangement of the exons in SULT1C1P (see Figure 2) .
While experimental data supported the computationally predicted gene structure for SULT6B1, 5 0 -RACE revealed that exon 2 was approximately half as long as originally predicted. This observation emphasizes the fact that even manually curated gene annotations require experimental confirmation and validation. 5 0 -RACE experiments identified four noncoding exons upstream of SULT6B1 exon 2, three of which served as sites of transcription initiation (Figure 3) . We also obtained evidence for the existence of several alternatively spliced mRNAs, but further studies will be required to determine the function-if any-of the encoded protein. Nonetheless, several observations can be made with regard to the predicted SULT6B1 protein sequence. First, the initial in-frame ATG in exon 2 matches the Kozak consensus sequence for translation initiation, 27 but that ATG would produce a protein that is approximately 20 amino acids shorter at the N-terminus than other human SULTs. Second, the predicted amino-acid sequence of SULT6B1 contains two gaps relative to other human SULTs, one located approximately 20 amino acids downstream of Region I and the other about five residues upstream of Region IV ( Figure 5 ). The first gap is aligned with gaps Figure 5 Human SULT sequences. An amino-acid sequence alignment of all SULT enzymes known to be expressed in humans. The highly conserved Regions I and IV are highlighted in blue and red, respectively. The dimerization interface region overlaps Region IV, and is underlined. The putative SULT1C3 gene might produce four separate isoforms as a result of alternative splicing. The sequences for two of those isoforms (1C3a and 1C3d) are shown, and those sequences can be used to assemble the sequences for 1C3b and 1C3c. The SULT2B1 gene produces two isoforms (2B1a and 2B1b) that differ only at the N terminus, so only SULT2B1a is shown. The SULT6B1 amino-acid sequence is based on the predicted translation of cDNAs. present in members of families 2 and 4, while the latter aligns with the gap present in human SULT4A1, which is predicted to enlarge the opening of the active site. Third, the dimerization motif present in other SULT sequences 7 is altered in two places in human SULT6B1. Specifically, the Glu residue that forms an ion pair in other SULTs is a Gln residue in SULT6B1 ( Figure 5 ). In addition, the conserved Val residue, which extends into the hydrophobic pocket in the dimer interface region, is a Glu residue in SULT6B1. This residue is also Glu in mouse SULT1E1, an isoform known to exist as a monomer, 7 and studies have shown that this change prevents dimerization. 7 Therefore, SULT6B1 may exist as a monomer.
Among the seven novel genes identified as a result of these studies, two, SULT1D2P and SULT3A1P, were processed pseudogenes, the first SULT processed pseudogenes described in any species. Furthermore, the SULT1C1P and SULT2A1P genes are the first unambiguous introncontaining SULT pseudogenes to be described in any species.
While our expression profiling and RACE experiments for SULT1C3 and SULT6B1 were being performed, the structure of the SULT1D1P gene was reported following an independent database search. 22 Our annotation confirms and refines the gene structures, map locations, and orientations described in that report. The SULT1D1P gene contains two stop codons in the putative exon 2 sequence. However, as a result of sequence divergence at the N-terminus of SULT enzymes, the initial coding exons of SULT genes are very difficult to predict accurately, so it is possible that an additional, functional exon 2 sequence exists farther upstream. Nonetheless, we concluded that SULT1D1P is a pseudogene. However, it must have been active in germline tissue at one time, since it has a corresponding processed pseudogene on chromosome 3. Unlike SULT1D1P, the 'active' SULT3A1 gene corresponding to the SULT3A1P processed pseudogene was not found, despite the fact that we searched with both the mouse SULT3A1 and predicted human SULT3A1 sequences. It is likely that the gene that gave rise to SULT3A1P has been deleted in the course of evolution.
Most human SULT genes are found in clusters, presumably formed through gene duplication events, although several solitary genes were also found. The orientation of all the genes in those clusters is head-to-tail, with the exception of the SULT2 cluster, which appears to have been subjected to at least one inversion. The annotations described in this study will provide additional insight into the evolution of the SULT gene family in humans and may aid in future studies of the regulation of these genes. In addition, these results will serve as a starting point for future comparative genomic studies of SULT genes in other species.
MATERIALS AND METHODS
Query Sequences
The protein query sequences used during the initial database searches were translated from the published cDNA sequences for human SULTs 1A1 (GenBank accession number 12 and 4A1 (AF188698). 47 To increase the specificity of the searches, the terminal 54 amino acids of SULT2B1, which compose the proline-rich tail unique to that isoform, were removed. Additional query sequences were mouse 1D1 (U32371), 48 mouse 3A1 (AF026075), mouse 5A1 (AF026074), chicken 6A1 (AF033189), 49 and the PFAM database 50, 51 consensus sequence for cytosolic sulfotransferases (pfam00685). A second consensus sequence was constructed from the 11 human SULT sequences using the GCG program Profilemake.
BLAST and Sequence Alignment Searches
To perform the initial screen of the human genome, 17 SULT sequences were selected as query sequences in a TBLASTN 23 search using a local copy of the RefSeq database (October 2001). The query sequences included the 11 SULT isoforms known to be expressed in humans, four non-human SULT sequences (mouse 1D1, mouse 3A1, mouse 5A1, and chicken 6A1), and the two different consensus sequences. For those searches, the BLOSUM62 scoring matrix was used and the expect parameter was set to 50. The results were annotated manually. Hits that did not correspond to known or novel SULT genes, or which were not obviously nonspecific (alignments that were very short or shared very low similarity, or those that should have encompassed portions of the highly conserved Region I and IV sequences but did not display any homology over those regions), were retained for further analysis. Redundancy was eliminated from the set of retained hits by preserving only a single 'marker' hit for each SULT gene and, since a 500 kb window of sequence was searched in the subsequent step, only the best hit in any given 100 kb window of genomic sequence was retained when a single query produced multiple hits within that window.
A 500 kb window of sequence was identified for each of the nonredundant hits. To increase the specificity of the searches, the query sequence that produced each of those hits was then divided into exon fragments (for the human SULTs only). Each window was then searched with either each of the exon sequences (human query sequences) or the intact peptide sequence (non-human or consensus sequences) as the query sequence, using two programsTFastA and FrameSearch. Both programs are from the GCG sequence analysis package, 52 are more sensitive sequence alignment programs than TBLASTN, and are designed to search a nucleotide database for similarity to a protein query sequence. The TFastA program employs the Pearson and Lipman k-tuple algorithm, and searches each reading frame independently. FrameSearch utilizes the Smith and Waterman algorithm for local alignments, and compares the query sequence to all possible codons on both strands of the nucleotide sequence, enabling it to identify significant sequence similarity even when frame shifts are present.
The number of hits produced by the two alignment programs was too large to annotate manually. Therefore, a filter was constructed using empirical data to reduce the number of hits that required annotation. The filter was designed after searching genomic contig sequences containing known SULT genes (positive controls) or random genomic sequence (negative controls), and analyzing the hits produced. Specifically, four SULT sequences (SULT1A1, SULT2A1, SULT4A1, and pfam00685) were each used to search three genomic contigs (NT_004610, NT_007874, and NT_008101) chosen at random, each approximately 500 kb in length. A total of 3080 hits were produced from those searches, and different methods of filtering the data were tested. The final filter criteria were found to be capable of eliminating most of the nonspecific hits, while retaining an adequate number of intermediate hits to allow the identification of novel SULT genes. In order for a hit to be retained for further analysis, it had to satisfy at least one of the three filter criteria. First, all hits at least 100 bp in length were retained so that long sequences with low percent identity were preserved. Second, all hits that shared at least 50% sequence identity to the query sequence and were at least 39 bp long were retained. That dual requirement eliminated the very short (but high percent identity) nonspecific hits, while still keeping all hits containing at least seven out of 13 matching amino acids. The third criterion, the product of the length and percent identity (LID), was designed to retain hits of both intermediate length and identity. Any hit with a LID score of at least 40 was retained. Of the 3080 hits from the random genomic contigs, 429 (14%) satisfied at least one of the three filter criteria. Therefore, approximately 12 hits are expected in every 500 kb of genomic sequence. This filter successfully reduced the number of hits that required manual annotation to a reasonable number, while still retaining a sufficient number of hits to allow the identification of novel SULT genes.
A visual display was developed to improve the efficiency of the manual annotation step. For each 500 kb window of sequence, all hits from the two searches that met or exceeded the filter criteria were plotted to illustrate graphically the quality and context of those hits (Figure 4 ). Four types of information were conveyed on each graph. The location of each hit within the sequence window was indicated on the x-axis. The exon used as a query sequence and whether the hit was on the forward or reverse strand were indicated on the y-axis. The program that produced the hit (color of data point) and either the length or percent identity of the hit (size of the data point) were also indicated. On these plots, hits corresponding to a single gene tend to cluster together and form a diagonal, whereas nonspecific hits are readily apparent due to their isolation and random scatter (Figure 4) . Microsoft Excel was used to create the plots, and a Visual Basic program was used to automate the process for all searches.
Following analysis of the first round of hits, seven novel SULT genes were identified. Since these sequences were not included as queries, the predicted amino-acid translations of four of them (SULTs 1C3, 1D1P, 6B1, and 3A1P) were used as query sequences for a second round of searches of the genome sequence database, using the same method described above. Those four sequences were chosen because they either represented a member of a new subfamily in humans or because they appeared to be functional genes.
HMMER and GeneWise Searches
A complementary approach to the BLAST-based method described above was also used. That strategy relied on HMMs rather than individual and explicit query sequences. The HMMER (version 2.2 g) 24 and GeneWise (version 2.2.0) 25 programs were chosen to perform those searches. A local HMM profile 26 was constructed from the sequences of the 11 human SULTs which are known to be expressed. Since HMMER requires a protein database, a six-fold translation of the human genome database was performed. The E and domE parameters were set to 0.01. After manual annotation of the HMMER hits, genomic contigs were identified that contained either a SULT gene or a hit that could not be unambiguously classified as nonspecific. GeneWise was then used to search those contigs in an attempt to refine the HMMER sequence alignments. The hits from the GeneWise searches were also annotated manually.
Annotation of SULT Genes
To annotate novel SULT genes, we took advantage of the high degree of conservation among SULT gene structures. 3 Specifically, the expected lengths of exons, the locations of splice junctions within the predicted cDNA, and the presence of GT/AG dinucleotides flanking exons were considered when annotating exons. Each hit corresponding to a SULT exon was refined using the GCG local sequence alignment program Gap. This process was used to annotate and assemble each of the gene structures manually. The map location and structure of each gene was verified using the most recent assembly of the NCBI human genome database (build 32). The structures of previously published genes were confirmed in a similar fashion. For those genes, the BLAST and Gap programs were used to compare the genomic sequence for each gene to reference mRNA sequences.
Expression Profiling of SULT1C3 and SULT6B1
Since there were no obvious inactivating mutations in the ORF or splice junctions of either SULT1C3 or SULT6B1, they appeared to be potentially functional genes. In an attempt to find evidence for their expression in humans, the predicted amino-acid sequences of SULT1C3 (isoforms SULT1C3a and SULT1C3d) and SULT6B1 were used as queries for TBLASTN searches of the human EST database. 53 The results of the searches were filtered such that only those hits that were at least 75% identical or that were more than 30 bp long with at least 90% similarity were retained. All alignments that met those criteria were examined manually.
To test experimentally for evidence of expression, 20 cDNAs (fetal lung, fetal brain, mammary gland, adrenal gland, and Multiple Tissue cDNA panels I and II) (Clontech, Palo Alto, CA) were used as template for the PCR with primers designed to hybridize with the predicted ORF sequences of SULT1C3 and SULT6B1 (primer sequences are available upon request). For SULT6B1, forward primers located in exons 2 and 3 were paired with reverse primers in exons 8 and 7, respectively, to perform nested PCR. Products were detected with testicular cDNA as template. Therefore, Marathon-Readyt human testis cDNA (Clontech) was used as template to characterize the transcripts further. For SULT1C3, the primers were located in exons 7 and 8, but no products were observed following PCR amplification using cDNA from 20 human tissues. Therefore, overlap extension 54 was used to construct a probe consisting of exons 5, 6, 7b, and 8b. The probe was radioactively labeled with 
SULT6B1 RACE and Transcript Characterization
To identify the site(s) of transcription initiation for SULT6B1, Marathon-Readyt human testis cDNA was used as template for 5 0 -and 3 0 -RACE. For 5 0 -RACE, reverse primers were designed near the 3 0 -end of the predicted exon 2 sequence and within exon 3. 3 0 -RACE was performed using a series of nested primers located in the predicted sequences of exons 7 and 8. The RACE products were cloned into pCR2.1 (Invitrogen, Carlsbad, CA, USA). To characterize the splicing patterns in full-length SULT6B1 transcripts, forward primers designed in exons 1D, 1C, and 1A were paired with reverse primers located in the 3 0 -UTR. The PCR products were cloned into pCR 3.1 Uni (Invitrogen). The Wizard Plus Miniprep DNA Purification System (Promega, Madison, WI, USA) was used to isolate the DNA prior to sequencing. Primer sequences are available upon request.
Cloning SULT6B1 From Other Primate Species To determine if SULT6B1 was present in other primate genomes, intron-based primers were designed that flanked each exon of the human gene sequence (sequences available upon request). Those primers were used to PCR amplify each exon from gorilla and chimpanzee genomic DNA (Coriell Cell Repositories Primate Panel, repository numbers NG05251 and NG06939, respectively). The products were sequenced and alignments with human sequences were constructed with the GCG program Pileup. 
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